Jaramillo Cartagena Alexis, Asowata Osaretin Emmanuel, Ng Dianna, Babady N Esther
Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cytology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Clin Microbiol. 2025 Mar 12;63(3):e0036124. doi: 10.1128/jcm.00361-24. Epub 2025 Feb 3.
() is a fungal pathogen associated with significant morbidity in immunocompromised patients, including both HIV- and non-HIV-infected patients. The nonspecific clinical and radiological presentation makes clinical diagnostic challenging, emphasizing the need for accurate laboratory diagnostic tests. However, does not grow in routine culture media, which presents diagnostic challenges in the laboratory as well. Recent publications from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium continue to rely on direct detection of organisms in tissues and respiratory samples to define proven pneumonia (PCP) even as the sensitivity of these methods are lower. Novel, standardized methods are needed to improve the clinical and laboratory diagnosis and management of PCP. This minireview provides an overview of current diagnostic tests for PCP and emerging applications that aim at filling existing diagnostic gaps and providing more accurate and less invasive diagnoses for this significant disease.
()是一种真菌病原体,与免疫功能低下患者的显著发病率相关,包括HIV感染和非HIV感染患者。非特异性的临床和影像学表现使得临床诊断具有挑战性,这凸显了准确实验室诊断测试的必要性。然而,()在常规培养基中不生长,这在实验室中也带来了诊断挑战。欧洲癌症研究与治疗组织和真菌病研究组教育与研究联盟最近的出版物继续依赖于在组织和呼吸道样本中直接检测()病原体来定义确诊的()肺炎(PCP),尽管这些方法的敏感性较低。需要新的标准化方法来改善PCP的临床和实验室诊断及管理。本综述概述了PCP的当前诊断测试以及旨在填补现有诊断空白并为这种重要疾病提供更准确、侵入性更小的诊断的新兴应用。